Status
Conditions
Treatments
About
The aim of this observational study is to determine the prevalence of OTOF gene variants among patients with auditory neuropathy spectrum disorder (ANSD). The primary research question is whether patients with ANSD carry a pathogenic or likely pathogenic OTOF gene variant. Participants will undergo genetic analysis of the OTOF gene.
Enrollment
Sex
Volunteers
Inclusion criteria
The study will be including 30 subjects of 30 patients of both sexes of any age with congenital hearing loss and confirmed diagnosis of non-syndromic ANSD:
A) Disproportionate speech discrimination score (SDS) with the hearing threshold level.
B)The auditory brainstem response (ABR) test with no waveform, disturbed waves, nor detectable wave V at high intense stimulus.
C) The otoacoustic emission (OAE) and/or cochlear microphonic (CM) potential may be present.
Informed consent.
Exclusion criteria
30 participants in 1 patient group
Loading...
Central trial contact
Mira Ayman Ramzy; Mostafa Ahmed Aly Youssif, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal